Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
1000 participants
INTERVENTIONAL
2007-11-30
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
IVMRI
Intra Vascular Magnetic Resonance Imaging
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IVMRI
Intra Vascular Magnetic Resonance Imaging
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient, or legal guardian, has been informed of the nature of the study, agrees to its provisions, and has sign the approved informed consent.
* The patient and the treating physician agree to attend the follow-ups as defined in the study protocol.
* Indication for diagnostic and/or interventional procedure.
* Lesions in a native vessels where IVMRI interrogation may provide additional information beyond angiography and other diagnostic tools.
Exclusion Criteria
* Tortuous vessels, calcified or thrombotic lesions.
* Significant stenosis of an unprotected left main coronary artery.
* IVMRI interrogation of an unprotected left main coronary artery.
* Patients with pacemaker or cardioverter defibrillator.
* The patient is suffering from transplant mediated coronary artery disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TopSpin Medical
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Wijns, Prof.
Role: PRINCIPAL_INVESTIGATOR
OLV Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sourasky Medical Center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Shmuel Banai, Prof.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCL-1.2-002
Identifier Type: -
Identifier Source: org_study_id